1Dhodapkar K, Krasovsky J, Williamson B, et al. Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specifie killer T cells by dendritic cells[J]. J Exp Med, 2002,195: 125. 被引量：1
2Clynes R. Antitumor antibodies in the treatment of cancer: Fc receptors link opsonic antibody with cellular immunity [J]. Hematol Oncol Clin North Am, 2006,20:585-612. 被引量：1
3Taylor C, Hershman D, Shah N, et al. Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy[J]. Clin Cancer Res, 2007,13:5133-5143. 被引量：1
4Lopez-Albaitero A, Lee S, Morgan S, et al. Role of poly morphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells[J]. Cancer Immunol Immunother, 2009,58 : 1853-1862. 被引量：1
5Roda JM, Parihar R, Magro C, et al. Natural killer cells produce T cell recruiting chemokines in response to antibody coated tumor cells[J]. Cancer Res, 2006,66: 517-526. 被引量：1
6Lucas M, Schachterle W, Oberle K, et al. Dendritic cells prime natural killer cells by trans presenting interleukin 15 [J]. Immunity,2007,26:503-517. 被引量：1
7Fridkin M, Eisenbach L. MHC class I-restricted epitope sprea ding in the context of tumor rejection following vaccination with a single immunodominant CTL epitope[J]. Eur J Immunol, 1999,29 : 3295-3301. 被引量：1
8Harbers S, Crocker A, Catalano G, et al. Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance[J]. J Clin Invest, 2007,117 : 1361-1369. 被引量：1
9Disis M, Wallace D, Gooley T, et al. Concurrent trastuaum ab and HER2/neu specific vaccination in patients with meta- static breast cancer[J]. J Clin Oncol, 2009,27 : 4685-4692. 被引量：1
10Lin W, Voskens C, Zhang X, etal. Fc-dependent expression of CD137 on human NK cells: insights into" agonistic" effects of anti-CD137 monoclonal antibodies[J]. Blood,2008, 112:699. 被引量：1
